Eliana Clark's most recent trade in Intellia Therapeutics Inc was a trade of 1,022 Common Stock done at an average price of $9.8 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 9.82 per share. | 01 Jul 2025 | 1,022 | 95,369 (0%) | 0% | 9.8 | 10,036 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 45,714 | 45,714 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 32,000 | 96,048 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 8.99 per share. | 01 Mar 2025 | 679 | 95,369 (0%) | 0% | 9.0 | 6,104 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 02 Jan 2025 | 7,422 | 64,048 (0%) | 0% | 12.2 | 90,400 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 02 Jan 2025 | 556 | 71,470 (0%) | 0% | 12.0 | 6,689 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 22.93 per share. | 01 Jul 2024 | 405 | 71,470 (0%) | 0% | 22.9 | 9,287 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 45,072 | 45,072 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 31,230 | 72,075 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 01 Mar 2024 | 605 | 71,470 (0%) | 0% | 33.0 | 19,959 | Common Stock |
| Intellia Therapeutics Inc | Clark Eliana | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 29.46 per share. | 03 Jan 2024 | 4,301 | 40,845 (0%) | 0% | 29.5 | 126,707 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 30.12 per share. | 03 Jan 2024 | 307 | 45,146 (0%) | 0% | 30.1 | 9,247 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 03 Jul 2023 | 360 | 45,146 (0%) | 0% | 40.5 | 14,584 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.27 per share. | 20 Jun 2023 | 5,000 | 50,146 (0%) | 0% | 12.3 | 61,350 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2023 | 5,000 | 57,750 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 20 Jun 2023 | 5,000 | 45,146 (0%) | 0% | 45 | 225,000 | Common Stock |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 34,674 | 34,674 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 24,539 | 39,012 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,134 | 45,146 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 15,395 | 15,395 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Eliana Clark | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 10,527 | 16,165 (0%) | 0% | 0 | Common Stock |